In stable CAD with type 2 diabetes, adding ticagrelor to aspirin reduced CV events but increased major bleeding
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- January 21, 2020
has subject area
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Aspirin (MeSH)
- Coronary Artery Disease (MeSH)
- Diabetes Mellitus, Type 2 (MeSH)
- Hemorrhage (MeSH)
- Humans (MeSH)
- Ticagrelor (MeSH)
published in
- ACP journal club Journal